US Stock MarketDetailed Quotes

CRDF Cardiff Oncology

Watchlist
  • 2.380
  • +0.250+11.74%
Close Aug 9 16:00 ET
  • 2.589
  • +0.209+8.77%
Post 20:01 ET
110.79MMarket Cap-2586P/E (TTM)

Cardiff Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-29.42%-9.23M
10.61%-7.74M
8.67%-30.89M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-46.79%-33.82M
-27.06%-9.39M
-36.98%-7.49M
Net income from continuing operations
-5.63%-11.78M
10.80%-10.01M
-7.07%-41.44M
-7.36%-9.34M
-13.53%-9.73M
-6.77%-11.15M
-2.09%-11.22M
-36.81%-38.7M
7.89%-8.7M
-23.98%-8.57M
Operating gains losses
----
----
----
----
----
----
----
100.35%1K
----
----
Depreciation and amortization
7.14%105K
13.33%102K
68.64%398K
19.77%103K
32.10%107K
157.89%98K
190.32%90K
-47.67%236K
-23.89%86K
-26.36%81K
Other non cash items
----
----
----
----
----
----
----
-93.16%139K
--0
--0
Change In working capital
-46.11%1.39M
-23.65%1.2M
1,828.42%6.57M
179.39%1.39M
791.22%1.02M
5.61%2.58M
270.24%1.57M
78.76%-380K
-8,660.00%-1.75M
76.55%-148K
-Change in receivables
-111.26%-58K
-210.53%-105K
304.66%483K
25.62%-90K
62.63%-37K
595.19%515K
7.95%95K
-9.77%-236K
14.18%-121K
-15.12%-99K
-Change in prepaid assets
-21.61%791K
-107.59%-95K
815.35%3.17M
95.75%-19K
6,728.57%928K
-12.94%1.01M
209.64%1.25M
78.89%-443K
67.08%-447K
98.27%-14K
-Change in payables and accrued expense
-38.26%673K
597.04%1.42M
110.01%2.83M
6,000.00%1.4M
421.43%135K
-20.26%1.09M
--203K
87.48%1.35M
-98.52%23K
-114.43%-42K
-Change in other current assets
28.70%139K
-14.81%138K
207.96%651K
122.80%243K
0.73%138K
-22.30%108K
-13.37%162K
-178.01%-603K
-946.03%-1.07M
-59.82%137K
-Change in other current liabilities
-9.22%-154K
-10.14%-152K
-26.91%-566K
-3.55%-146K
-8.46%-141K
-20.51%-141K
-137.93%-138K
53.88%-446K
28.06%-141K
64.67%-130K
Cash from discontinued investing activities
Operating cash flow
-29.42%-9.23M
10.61%-7.74M
8.67%-30.89M
23.97%-7.14M
-6.29%-7.96M
-6.53%-7.13M
15.51%-8.66M
-46.79%-33.82M
-27.06%-9.39M
-36.98%-7.49M
Investing cash flow
Cash flow from continuing investing activities
22.04%14.02M
-36.74%4.64M
-5.12%36.2M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
129.02%38.15M
179.83%7.02M
-35.86%5.16M
Capital expenditure reported
--0
-900.00%-80K
42.15%-582K
89.33%-8K
29.69%-315K
19.55%-251K
95.32%-8K
-390.73%-1.01M
29.91%-75K
-357.14%-448K
Net investment purchase and sale
19.43%14.02M
-35.72%4.72M
-5.80%36.78M
91.25%13.57M
-25.72%4.14M
49.51%11.74M
-60.40%7.34M
129.75%39.04M
181.67%7.1M
-31.66%5.57M
Net other investing changes
----
----
----
----
----
----
----
--114K
--0
--43K
Cash from discontinued investing activities
Investing cash flow
22.04%14.02M
-36.74%4.64M
-5.12%36.2M
93.18%13.56M
-25.99%3.82M
50.95%11.48M
-60.08%7.33M
129.02%38.15M
179.83%7.02M
-35.86%5.16M
Financing cash flow
Cash flow from continuing financing activities
2.06M
107K
0
0
0
0
0
-99.79%75K
0
Proceeds from stock option exercised by employees
--253K
--107K
--0
--0
--0
--0
--0
-94.06%75K
--0
----
Cash from discontinued financing activities
Financing cash flow
--2.06M
--107K
--0
--0
--0
--0
--0
-99.79%75K
--0
--75K
Net cash flow
Beginning cash position
24.25%18.66M
32.47%21.66M
36.88%16.35M
-18.61%15.23M
-7.61%19.37M
-25.11%15.02M
36.88%16.35M
-90.88%11.94M
42.17%18.72M
98.14%20.97M
Current changes in cash
57.24%6.84M
-125.34%-3M
20.53%5.31M
370.97%6.42M
-83.99%-4.14M
376.67%4.35M
-116.40%-1.33M
103.70%4.4M
-93.94%-2.37M
-187.00%-2.25M
End cash Position
31.66%25.5M
24.25%18.66M
32.47%21.66M
32.47%21.66M
-18.61%15.23M
-7.61%19.37M
-25.11%15.02M
36.88%16.35M
36.88%16.35M
42.17%18.72M
Free cash flow
-25.02%-9.23M
9.77%-7.82M
9.64%-31.47M
24.49%-7.15M
-4.26%-8.27M
-5.37%-7.38M
16.82%-8.67M
-49.82%-34.83M
-26.25%-9.47M
-42.62%-7.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -29.42%-9.23M10.61%-7.74M8.67%-30.89M23.97%-7.14M-6.29%-7.96M-6.53%-7.13M15.51%-8.66M-46.79%-33.82M-27.06%-9.39M-36.98%-7.49M
Net income from continuing operations -5.63%-11.78M10.80%-10.01M-7.07%-41.44M-7.36%-9.34M-13.53%-9.73M-6.77%-11.15M-2.09%-11.22M-36.81%-38.7M7.89%-8.7M-23.98%-8.57M
Operating gains losses ----------------------------100.35%1K--------
Depreciation and amortization 7.14%105K13.33%102K68.64%398K19.77%103K32.10%107K157.89%98K190.32%90K-47.67%236K-23.89%86K-26.36%81K
Other non cash items -----------------------------93.16%139K--0--0
Change In working capital -46.11%1.39M-23.65%1.2M1,828.42%6.57M179.39%1.39M791.22%1.02M5.61%2.58M270.24%1.57M78.76%-380K-8,660.00%-1.75M76.55%-148K
-Change in receivables -111.26%-58K-210.53%-105K304.66%483K25.62%-90K62.63%-37K595.19%515K7.95%95K-9.77%-236K14.18%-121K-15.12%-99K
-Change in prepaid assets -21.61%791K-107.59%-95K815.35%3.17M95.75%-19K6,728.57%928K-12.94%1.01M209.64%1.25M78.89%-443K67.08%-447K98.27%-14K
-Change in payables and accrued expense -38.26%673K597.04%1.42M110.01%2.83M6,000.00%1.4M421.43%135K-20.26%1.09M--203K87.48%1.35M-98.52%23K-114.43%-42K
-Change in other current assets 28.70%139K-14.81%138K207.96%651K122.80%243K0.73%138K-22.30%108K-13.37%162K-178.01%-603K-946.03%-1.07M-59.82%137K
-Change in other current liabilities -9.22%-154K-10.14%-152K-26.91%-566K-3.55%-146K-8.46%-141K-20.51%-141K-137.93%-138K53.88%-446K28.06%-141K64.67%-130K
Cash from discontinued investing activities
Operating cash flow -29.42%-9.23M10.61%-7.74M8.67%-30.89M23.97%-7.14M-6.29%-7.96M-6.53%-7.13M15.51%-8.66M-46.79%-33.82M-27.06%-9.39M-36.98%-7.49M
Investing cash flow
Cash flow from continuing investing activities 22.04%14.02M-36.74%4.64M-5.12%36.2M93.18%13.56M-25.99%3.82M50.95%11.48M-60.08%7.33M129.02%38.15M179.83%7.02M-35.86%5.16M
Capital expenditure reported --0-900.00%-80K42.15%-582K89.33%-8K29.69%-315K19.55%-251K95.32%-8K-390.73%-1.01M29.91%-75K-357.14%-448K
Net investment purchase and sale 19.43%14.02M-35.72%4.72M-5.80%36.78M91.25%13.57M-25.72%4.14M49.51%11.74M-60.40%7.34M129.75%39.04M181.67%7.1M-31.66%5.57M
Net other investing changes ------------------------------114K--0--43K
Cash from discontinued investing activities
Investing cash flow 22.04%14.02M-36.74%4.64M-5.12%36.2M93.18%13.56M-25.99%3.82M50.95%11.48M-60.08%7.33M129.02%38.15M179.83%7.02M-35.86%5.16M
Financing cash flow
Cash flow from continuing financing activities 2.06M107K00000-99.79%75K0
Proceeds from stock option exercised by employees --253K--107K--0--0--0--0--0-94.06%75K--0----
Cash from discontinued financing activities
Financing cash flow --2.06M--107K--0--0--0--0--0-99.79%75K--0--75K
Net cash flow
Beginning cash position 24.25%18.66M32.47%21.66M36.88%16.35M-18.61%15.23M-7.61%19.37M-25.11%15.02M36.88%16.35M-90.88%11.94M42.17%18.72M98.14%20.97M
Current changes in cash 57.24%6.84M-125.34%-3M20.53%5.31M370.97%6.42M-83.99%-4.14M376.67%4.35M-116.40%-1.33M103.70%4.4M-93.94%-2.37M-187.00%-2.25M
End cash Position 31.66%25.5M24.25%18.66M32.47%21.66M32.47%21.66M-18.61%15.23M-7.61%19.37M-25.11%15.02M36.88%16.35M36.88%16.35M42.17%18.72M
Free cash flow -25.02%-9.23M9.77%-7.82M9.64%-31.47M24.49%-7.15M-4.26%-8.27M-5.37%-7.38M16.82%-8.67M-49.82%-34.83M-26.25%-9.47M-42.62%-7.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-4.29%